Length of Royalty Payments. The royalties payable to Lilly ------ -- ---------------- under Section 6.2.2 of this Agreement shall be paid on a country-by-country basis from the date of first commercial sale of each such Product in a particular country until ten (10) years thereafter.
Length of Royalty Payments. The royalties payable under subsections (a) and (b)(i) shall be paid on a country-by-country basis on each Product or Other Product, as applicable, from the First Commercial Sale until the expiration of all Assigned Patent Rights and/or PNG Patent Rights that cover such Product or Other Product, as applicable, in such country. (d)
Length of Royalty Payments. The royalties payable under subsection (a) shall be paid until the expiration of all Patent Rights listed on Schedule 1.4 (as updated pursuant hereto) that cover such Derivative. (c)
Length of Royalty Payments. 52 Section 4.10 Royalties Payable Only Once.............................. 52 Section 4.11 Royalty Reports and Accounting........................... 53 Section 4.12 Currency and Method of Payments; Late Payments........... 53 Section 4.13
Length of Royalty Payments. The royalties payable under Section 6.3(a) shall be paid on a country-by-country basis from the date of First Commercial Sale of each MBI Small Molecule Drug in a particular country until ***************** after such First Commercial Sale in such country.
Length of Royalty Payments. 45 Section 8.7. Royalties Payable Only Once. ......................... 46 Section 8.8.
Length of Royalty Payments. The royalties payable under Sections 8.5 shall be paid on a country-by-country basis from the date of First Commercial Sale for each Product until the termination of any Legal Exclusivity afforded such Product in such country, or until [**] years after such First Commercial Sale, whichever is longer. Notwithstanding the foregoing, all obligations of Astra to pay royalties to Millennium on the Net Sales of Products pursuant to Section 8.5 shall [**]. Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
Length of Royalty Payments. Royalties shall be paid under this Exhibit A-2, on a country-by-country and Royalty Bearing Product- by-Royalty Bearing Product basis, on Net Sales of any Royalty Bearing Product during the Royalty Term.
Length of Royalty Payments. The royalties payable under Section 4.4 shall be paid on a country-by-country basis on each Royalty-Bearing Product until the expiration of the Royalty Term.
Length of Royalty Payments. The royalties payable under this Article III shall be paid [*****] on each such Program Product or Third Party Pharmacogenomic Product until the later of (a) the expiration of all Program Patent Rights which cover such Program Product or Third Party Pharmacogenomic Product [*****] (b) [*****]after the First Commercial Sale of such Program Product or Third Party Pharmacogenomic Product [*****].
